Clinical Trial Update: Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating retinoids to silence autoantigens in ANCA-associated vasculitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

Drugs mentioned

• Retinoids

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Phase 2 | Status: WITHDRAWN